Skip to main content
58°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics, Inc. - Common Stock
(NQ:
AXNX
)
70.98
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axonics, Inc. - Common Stock
< Previous
1
2
3
Next >
Axonics Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
September 26, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
September 18, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
May 16, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From
Axonics, Inc.
Via
Business Wire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
April 30, 2024
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Via
MarketBeat
Axonics Stockholders Approve Merger Agreement with Boston Scientific
March 22, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From
Axonics, Inc.
Via
Business Wire
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
January 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
Axonics, Inc.
Via
Business Wire
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
November 06, 2023
From
NeuroQure
Via
GlobeNewswire
Axonics to Participate in November Investor Conferences
November 01, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Third Quarter 2023 Financial Results
October 30, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report Third Quarter 2023 Financial Results on October 30
October 02, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Participate in September Investor Conferences
August 25, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Announces CFO Retirement and Appoints Successor
August 21, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Second Quarter 2023 Financial Results
July 27, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report Second Quarter 2023 Financial Results on July 27
June 29, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports First Quarter 2023 Financial Results
May 01, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Participate in Upcoming Investor Conferences
April 25, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
April 24, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report First Quarter 2023 Financial Results on May 1
April 10, 2023
From
Axonics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
